Guided Therapeutics (OTCMKTS:GTHP) Issues Quarterly Earnings Results

Guided Therapeutics (OTCMKTS:GTHP) posted its quarterly earnings data on Monday. The company reported ($0.02) EPS for the quarter, Zacks reports.

Guided Therapeutics Price Performance

Shares of GTHP stock opened at $0.10 on Tuesday. Guided Therapeutics has a fifty-two week low of $0.06 and a fifty-two week high of $0.23. The firm’s 50 day moving average price is $0.11 and its two-hundred day moving average price is $0.15. The stock has a market cap of $7.76 million, a price-to-earnings ratio of -3.32 and a beta of 0.50.

About Guided Therapeutics

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.